LearnGlossaryMarketStocksSuperinvestorsSign in

CLPT

ClearPoint Neuro, Inc.

Healthcare · $360M market cap

Verdict

We can't put a fair value on CLPT right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth12.1% a year✓
Sales growth22.0% a year✓
Free cash flow growth—?
Return on invested capital-52.6%✗

Follow CLPT

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 2, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

BURNETT JOSEPH

CEO and President · 2026-09-02

Option exercise

$43K

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works